|
Recruiting
|
NCT04561557 -
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
|
Early Phase 1 |
|
Completed
|
NCT05645185 -
Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient
|
|
|
Completed
|
NCT04708626 -
Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden
|
|
|
Not yet recruiting
|
NCT04106596 -
HLA Analysis in Autoimmune Encephalitis and Related Disorders
|
|
|
Not yet recruiting
|
NCT05711563 -
Predicting and Monitoring Outcomes in Autoimmune Encephalitis
|
|
|
Completed
|
NCT04175522 -
Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
|
Phase 2 |
|
Recruiting
|
NCT03194815 -
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
|
Phase 2 |
|
Not yet recruiting
|
NCT03957616 -
Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis
|
|
|
Completed
|
NCT02905136 -
Mechanisms of Auto-immune Encephalitis
|
|
|
Recruiting
|
NCT05280600 -
Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis
|
|
|
Recruiting
|
NCT06173076 -
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
|
|
|
Recruiting
|
NCT03993262 -
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
|
Phase 2 |
|
Recruiting
|
NCT06033846 -
Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis
|
Phase 2 |
|
Recruiting
|
NCT04372615 -
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
|
Phase 2 |
|
Recruiting
|
NCT05177939 -
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
|
Phase 3 |
|
Recruiting
|
NCT06019975 -
FDG-PET in the Diagnosis of Autoimmune Encephalitis
|
|
|
Completed
|
NCT05783947 -
Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies
|
|
|
Completed
|
NCT05825690 -
BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis
|
|
|
Not yet recruiting
|
NCT06079294 -
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
|
N/A |
|
Recruiting
|
NCT03872284 -
Neuro-ophthalmology and Autoimmune Encephalitis (NODE)
|
|